OpenVSafe by OpenVAERS
Search V-safe

AYC-28318-44579

2 vaccinations 8 coded responses 12 check-ins 8 free-text entries 3 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
112 / NY
Registered
2021-02-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-14
    Dose 1 — Moderna
  2. 2021-02-27
    Dose 2 — Moderna
  3. 2021-02-28
    Registered in v-safe
  4. 2021-02-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Disorientation, Dizziness, Dysgeusia, Feeling abnormal — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Metallic taste in mouth, poor appetite, disoriented feeling, dizziness, mentally foggy and slow
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Facial pain, Feeling abnormal, Lacrimation increased, Memory impairment, Pain in jaw, Periorbital pain, Photophobia, Toothache — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Pain in eye sockets, jaw, teeth and cheekbones, photophobia, eyes intermittently tearing, mental fog and poor memory
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nausea, Retching — Feeling: Fair · Site: Swelling · Fatigue or tiredness, Nausea
    Free text: Queasy with dry heaves at 4 AM
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Gastrointestinal disorder — Feeling: Good · Headache, Abdominal pain
    Free text: GI disturbance for 36 hours
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to work
    Adult check-in
  9. 2021-03-06
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-03-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-03-27
    Survey response — day 28, dose 2
    MedDRA: Headache — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Intractable headache for 96 hours
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-03
    Survey response — day 35, dose 2
    MedDRA: Eye injury, Hypertensive crisis — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Hypertensive crisis (BP 210/120, no previous diagnosis of HTN, resulting in vision injury)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-03
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-04-12
    Survey response — day 42, dose 2
    MedDRA: Headache, Hypertensive emergency, Oedema, Oedema peripheral, Specialist consultation — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Lower extremity +3 pitting edema following sudden onset hypertensive emergency; frequent intermittent intractable right frontal headache; now referred for MRA and MRI to rule out embolism and aneurism · Healthcare visit (other): Visits with primary HCP, optometrist, referral to neurologist and testing, labs drawn
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-12
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-06-15
  18. 2021-06-21
  19. 2021-08-28
    Survey response — 6 months, dose 2
    MedDRA: Biopsy kidney abnormal, IgA nephropathy, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Symptoms: New Dx IgA Nephropathy with symptom onset 3 weeks s/p dose #2 SARS-CoV-2 vax (Moderna). Biopsy confirmed. No previous hx HTN, CKD, or diabetes. Not infection-associated. https://www.sciencedirect.com/science/article/pii/S2590059521001552 · Healthcare visit (other): Primary HCP w referrals to nephrology, urology, cardiology, interventional radiology. Imaging studies: CT scan, MRIs, CXR, renal sonogram, cystoscopy, echo, stress test. Numerous and repeated laboratory testing
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  20. 2021-08-28
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  21. 2021-08-31
  22. 2021-09-03
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Moderna
22021-02-27Moderna

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-28

Systemic reaction (other): Metallic taste in mouth, poor appetite, disoriented feeling, dizziness, mentally foggy and slow

2021-03-01

Systemic reaction (other): Pain in eye sockets, jaw, teeth and cheekbones, photophobia, eyes intermittently tearing, mental fog and poor memory

2021-03-02

Systemic reaction (other): Queasy with dry heaves at 4 AM

Release 5 — days 1–6 daily, dose 2

2021-03-03

Systemic reaction (other): GI disturbance for 36 hours

Release 6 — day 28, dose 2

2021-03-27

Symptoms: Intractable headache for 96 hours

Release 6 — day 35, dose 2

2021-04-03

Symptoms: Hypertensive crisis (BP 210/120, no previous diagnosis of HTN, resulting in vision injury)

Release 7 — day 42, dose 2

2021-04-12

Symptoms: Lower extremity +3 pitting edema following sudden onset hypertensive emergency; frequent intermittent intractable right frontal headache; now referred for MRA and MRI to rule out embolism and aneurism
Healthcare visit (other): Visits with primary HCP, optometrist, referral to neurologist and testing, labs drawn

Release 9 — 6 months, dose 2

2021-08-28

Symptoms: New Dx IgA Nephropathy with symptom onset 3 weeks s/p dose #2 SARS-CoV-2 vax (Moderna). Biopsy confirmed. No previous hx HTN, CKD, or diabetes. Not infection-associated. https://www.sciencedirect.com/science/article/pii/S2590059521001552
Healthcare visit (other): Primary HCP w referrals to nephrology, urology, cardiology, interventional radiology. Imaging studies: CT scan, MRIs, CXR, renal sonogram, cystoscopy, echo, stress test. Numerous and repeated laboratory testing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ · ✓
HCVOSpecialist consultation ✓ ✓ ✓
SDBiopsy kidney abnormal ✓ · ✓
SDEye injury ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypertensive crisis ✓ ✓ ✓
SDHypertensive emergency ✓ ✓ ✓
SDIgA nephropathy ✓ · ✓
SDOedema ✓ ✓ ✓
SDOedema peripheral ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRODisorientation ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODysgeusia ✓ ✓ ✓
SROFacial pain ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROGastrointestinal disorder ✓ ✓ ✓
SROLacrimation increased ✓ ✓ ✓
SROMemory impairment ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROPain in jaw ✓ ✓ ✓
SROPeriorbital pain ✓ ✓ ✓
SROPhotophobia ✓ ✓ ✓
SRORetching ✓ ✓ ✓
SROToothache ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release